112
report
Learning from COVID-19: Reimagining Public-Private Partnerships in Public Health
The Milken Institute Center for Public Health leveraged our network of thought leaders to maximize
learnings from the COVID-19 pandemic, focused on examining the private sector’s role and responsibility in supp
+ Read More
report
Creating a Nonprofit Marketplace for Shelved Drugs: Lessons from a Pilot Project
Many promising medicines, despite strong safety data and pharmaceutical characteristics, are discon
tinued by drug companies for nonscientific reasons, including strategic, organizational, and financial considerations.
+ Read More
report
Hedging Pipeline Risk in Pharma: FDA Swaps and Annuities
The cost of capital to conduct medical R&D is high because investors must be compensated with s
ignificant returns to offset the risky and long drug-development process.
+ Read More
report
Public-Private Infrastructure Financing Solutions
Infrastructure is the backbone of a nation’s economic prosperity and crucial for growth.
report
Designing an Israeli Development Financing Platform
On January 8, 2019, in a joint venture with the Prime Minister’s Office, the Milken Innovation Cent
er/Blum Lab for Developing Economies hosted a Financial Innovations Lab to explore the creation of an Israeli development finance institution (DFI).
+ Read More
report
Financing Urban Resiliency: Innovative Approaches to Deliver Affordable Housing in Chicago
In many US cities, concentrated poverty and chronic disinvestment have resulted in wide social, eco
nomic, and geographic disparities.
+ Read More
report
Investing in Los Angeles' Urban Resiliency - Executive Summary
Most countries are underinvesting in their efforts to deal with expected population increases and c
limate stresses, producing an annual global shortfall of US$350B in global infrastructure spending.
+ Read More
report
Financing Lung Cancer Screening in China
Lung cancer, one of the most preventable diseases, surpasses all other cancer deaths worldwide.
report
Nonprofits: A Growing Force in Drug Development
Shepherding a drug from discovery to the market is a complex process that involves many actors.
report
From Recovery to Resilience: How Opportunity Zones Can Help Accelerate Post-COVID Economic Resurgence
The COVID-19 pandemic presents an unprecedented challenge to all economies. However, pandemics hit
underserved and vulnerable populations the hardest, and now the crisis will exacerbate their need for capital.
+ Read More
report
Patient-Focused Drug Development Meetings: Smart Practices from Community Leaders
FasterCures, a center of the Milken Institute, designed this guide for patient advocacy organizatio
ns that are interested in hosting, or are currently planning, an externally led patient-focused drug development (PFDD)
+ Read More
report
GBM: Giving Smarter
Glioblastoma Multiforme (GBM) is an aggressive malignant brain tumor involving glial cells of the b
rain. At the time of this report, nearly 15,000 people were diagnosed with GBM each year in the United States and Europe.
+ Read More